Hegseth Wants More Testosterone, Doctors Say It Will Make Troops Infertile

U.S. Defense Secretary Pete Hegseth has mandated annual testosterone-deficiency screening for active-duty and reserve service members aged 30 and older, a policy choice aimed at enhancing combat readiness that has drawn immediate skepticism from medical experts.

Clinicians warn that the directive lacks robust scientific support and could inadvertently cause health complications, including infertility, if the hormone is inappropriately prescribed.

A Question of Readiness

Hegseth framed the voluntary testing initiative as a mechanism to optimize troop performance, resilience, and longevity.

The mandate is specifically intended to address "Operator Syndrome," a complex condition involving low testosterone, traumatic brain injuries, and metabolic dysregulation observed in elite units like the Navy SEALs and Delta Force.

However, medical professionals argue that elite special forces are not representative of the broader military population.

Dr. B. Christopher Frueh of the University of Hawaii, whose team first described the syndrome, told Reuters that standard personnel do not face the same extreme physiological demands as special operators.

“These operators are at an extreme end of a spectrum,” Frueh said. “They have much higher exposures to blasts, airplane jumps, firing all kinds of different weapons, shoulder-fired rockets, and machine guns.”

Risks of Overtreatment

Five out of six men's health experts questioned the utility of the universal age-30 threshold, noting that broad screenings frequently lead to unnecessary medical interventions.

Standard clinical guidelines from the American Urological Association and the Endocrine Society restrict testosterone supplements to patients displaying explicit symptoms such as fatigue, reduced bone density, and decreased libido.

Administering testosterone in the absence of clinical symptoms presents significant physiological risks.

Beyond the potential for blood thickening, prostate issues, and mood volatility, experts highlighted a severe threat to reproductive health.

“If you just dole out the testosterone, the testes will shrink. And you can't reliably count on them coming back,” warned Dr. Kevin McVary, a urologist on the medical advisory board of Rugiet.

Policy Shifts and Analytical Gaps

The Pentagon has declined to elaborate on how abnormal screening results will be managed or whether the protocol will differ between male and female personnel.

The order marks the latest in a series of controversial healthcare shifts under the current administration, which recently included the temporary reversal of the military's influenza vaccine mandate.

While some practitioners note that broader screening could reveal correctable, non-hormonal health issues, such as weight-related deficiencies among reservists, the consensus leans toward preliminary study before full deployment.

Implementing universal testing without baseline data, specialists warn, represents a significant procedural misstep.